Several analysts have recently updated their ratings and price targets for Procter & Gamble Company (The) (NYSE: PG):

  • 8/3/2017 – Procter & Gamble Company (The) was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “P&G reported fourth-quarter fiscal 2017 results, wherein earnings and revenues surpassed expectations. Adjusted earnings increased 8% year over year but net sales remained unchanged with the year-ago level. The earnings growth was encouraging in light of solid organic sales growth and operating margin expansion (up 210 basis points or bps) aided by productivity cost savings (up 350 bps). SG&A expenses, as a percentage of sales, were also down 220 bps aided by cost savings. Overall organic sales were up 2% comprising 2% volume growth. All five business segments achieved organic volume growth despite deceleration in market growth. P&G’s online organic sales also improved 30% and represent over 5% of total revenue. The company remains focused on balanced growth through improved product, packaging, and marketing initiatives and productivity cost saving plan ($10 billion over the next five years).”
  • 8/1/2017 – Procter & Gamble Company (The) was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $101.00 price target on the stock. According to Zacks, “P&G reported fourth-quarter fiscal 2017 results, wherein earnings and revenues surpassed expectations. Adjusted earnings increased 8% year over year but net sales remained unchanged with the year-ago level. The earnings growth was encouraging in light of solid organic sales growth and operating margin expansion (up 210 basis points or bps) aided by productivity cost savings (up 350 bps). SG&A expenses, as a percentage of sales, were also down 220 bps aided by cost savings. Overall organic sales were up 2% comprising 2% volume growth. All five business segments achieved organic volume growth despite deceleration in market growth. P&G’s online organic sales also improved 30% and represent over 5% of total revenue. The company remains focused on balanced growth through improved product, packaging, and marketing initiatives and productivity cost saving plan ($10 billion over the next five years).”
  • 7/31/2017 – Procter & Gamble Company (The) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 7/30/2017 – Procter & Gamble Company (The) had its “hold” rating reaffirmed by analysts at Stifel Nicolaus. They now have a $90.00 price target on the stock, up previously from $87.00.
  • 7/30/2017 – Procter & Gamble Company (The) had its “outperform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a $100.00 price target on the stock, up previously from $98.00.
  • 7/22/2017 – Procter & Gamble Company (The) had its “hold” rating reaffirmed by analysts at Deutsche Bank AG. They now have a $92.00 price target on the stock, up previously from $90.00.
  • 7/17/2017 – Procter & Gamble Company (The) had its “buy” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $98.00 price target on the stock. They wrote, “Trian has filed a prelim proxy statement to nominate Nelson Peltz to P&G’s Board. While P&G has taken sensible steps to drive shareholder value, results/ TSR have lagged. Mr. Peltz is neither looking to split-up P&G nor replace its current CEO, and specifics behind his plan to improve profitability/ performance still ambiguous. However, we continue to believe his involvement raises the execution bar at P&G, which is supportive of a higher multiple. Trian has launched a campaign to elect Nelson Peltz to P&G’s Board at the company’s 2017 Annual Meeting: Press reports initially surfaced in February of Trian’s $3.3B stake in P&G and the activist is now going public after four months of discussion with the company failed to land Mr. Peltz a seat on the Board. Perhaps even more noteworthy than the areas where Mr. Peltz is looking to be an agent for change (i.e. excessive cost, bureaucracy, market share losses) are those areas where he is not (i.e. neither looking to break-up P&G nor replace CEO David Taylor). The investment community will surely hear more in the coming months as Mr. Peltz makes his case publicly (including public interviews this morning).””
  • 7/12/2017 – Procter & Gamble Company (The) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 7/7/2017 – Procter & Gamble Company (The) was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “P&G is known for its strong brand recognition, diversified portfolio, impressive product development capabilities and marketing prowess as well as strong cash flow productivity. The company is investing in its brands and products as well as redesigning the supply chain to improve productivity and organic growth. However, P&G has been struggling for the last few quarters to boost sales. Major foreign exchange headwind, weak volumes, divestitures and slowing market growth have been hurting sales. Soft consumer-spending environment in developed markets also adds to the worries. That said, P&G is speeding up innovations and investments to counter the softening industry growth. Its productivity improvements and aggressive cost-saving efforts are also consistently helping to boost profit level.”
  • 7/3/2017 – Procter & Gamble Company (The) was downgraded by analysts at Vetr from a “hold” rating to a “sell” rating. They now have a $83.75 price target on the stock.
  • 6/30/2017 – Procter & Gamble Company (The) had its “hold” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $80.00 price target on the stock.
  • 6/22/2017 – Procter & Gamble Company (The) was downgraded by analysts at Capital One Financial Corporation from an “overweight” rating to an “equal weight” rating. They now have a $2.00 price target on the stock, down previously from $5.00.

Shares of Procter & Gamble Company (PG) traded down 0.20% during mid-day trading on Thursday, reaching $91.74. The company’s stock had a trading volume of 6,338,248 shares. Procter & Gamble Company has a 12-month low of $81.18 and a 12-month high of $92.00. The stock has a market capitalization of $233.94 billion, a P/E ratio of 16.40 and a beta of 0.68. The company’s 50-day moving average price is $88.92 and its 200-day moving average price is $88.88. Procter & Gamble Company (The) also was the target of unusually large options trading on Monday. Stock traders purchased 35,861 call options on the company. This is an increase of approximately 509% compared to the typical daily volume of 5,886 call options.

Procter & Gamble Company (The) (NYSE:PG) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.78 by $0.07. Procter & Gamble Company (The) had a return on equity of 19.97% and a net margin of 23.56%. The business had revenue of $16.08 billion for the quarter, compared to the consensus estimate of $16.01 billion. During the same quarter in the previous year, the company posted $0.79 EPS. The company’s revenue was down .1% compared to the same quarter last year. On average, equities research analysts forecast that Procter & Gamble Company will post $4.17 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Friday, July 21st will be paid a $0.6896 dividend. This represents a $2.76 dividend on an annualized basis and a yield of 3.01%. The ex-dividend date of this dividend is Wednesday, July 19th. Procter & Gamble Company (The)’s payout ratio is 49.37%.

In other news, insider Patrice Louvet sold 62,350 shares of Procter & Gamble Company (The) stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $86.27, for a total value of $5,378,934.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Suranjan Magesvaran sold 10,512 shares of Procter & Gamble Company (The) stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $91.00, for a total value of $956,592.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 203,898 shares of company stock worth $17,666,387. Corporate insiders own 0.35% of the company’s stock.

The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.

Receive News & Ratings for Procter & Gamble Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.